Shire: AbbVie should proceed with $55B acquisition
Wednesday, October 15, 2014 - 08:30
in Mathematics & Economics
The drugmaker Shire wants AbbVie to stick with its roughly $55 billion acquisition bid, and it is reminding its U.S. counterpart of the hefty breakup fee it could receive if things don't work out.